World's Best Scientists 2026 revealed!
Jeffrey A. Lieberman

Jeffrey A. Lieberman

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
179
Citations
130910
World Ranking
629
National Ranking
393

Medicine

D-Index
183
Citations
134645
World Ranking
328
National Ranking
205

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Jeffrey A. Lieberman is affiliated with Columbia University in the United States. Their research primarily spans the field of Medicine, with a concentrated focus on Psychiatry and Mental Health, Radiology, Nuclear Medicine and Imaging, Cognitive Neuroscience, Biological Psychiatry, and Clinical Psychology.

The scientist has a significant publication record, with 79 works in Medicine and numerous contributions to subfields including psychiatry and mental health (33 publications), radiology, nuclear medicine and imaging (19), cognitive neuroscience (16), biological psychiatry (14), and clinical psychology (13).

The main topics covered in their research encompass schizophrenia research and treatment, tryptophan and brain disorders, functional brain connectivity studies, diet and metabolism studies, neuroscience and neuropharmacology research, advanced MRI techniques and applications, and advanced neuroimaging techniques and applications.

Frequent collaborators include T. Scott Stroup, Ragy R. Girgis, Joseph P. McEvoy, Sonia M. Davis, and Richard S.E. Keefe.

Lieberman's work has appeared predominantly in venues such as UNC Libraries, Schizophrenia Research, JAMA Psychiatry, New England Journal of Medicine, and bioRxiv (Cold Spring Harbor Laboratory).

Recent publications include:

  • How mental health care should change as a consequence of the COVID-19 pandemic, 2020, The Lancet Psychiatry
  • Muscarinic Cholinergic Receptor Agonist and Peripheral Antagonist for Schizophrenia, 2021, New England Journal of Medicine
  • Efficacy and Safety of Lumateperone for Treatment of Schizophrenia, 2020, JAMA Psychiatry
  • Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder, 2021, Translational Psychiatry
  • Neurodegenerative model of schizophrenia: Growing evidence to support a revisit, 2022, Schizophrenia Research

Best Publications

  • Biological insights from 108 schizophrenia-associated genetic loci

    Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Aiden Corvin;James T. R. Walters

  • Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

    Jeffrey A. Lieberman;T. Scott Stroup;Joseph Patrick McEvoy;Joseph Patrick McEvoy;Marvin S. Swartz

  • Genome-wide association study identifies five new schizophrenia loci

    Stephan Ripke;Alan R. Sanders;Kenneth S. Kendler;Douglas F. Levinson

  • Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs

    S. Hong Lee;Stephan Ripke;Stephan Ripke;Benjamin M. Neale;Benjamin M. Neale;Stephen V. Faraone

  • Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder.

    Delbert Robinson;Margaret G. Woerner;Jose Ma. J. Alvir;Robert Bilder

  • Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

    Diana O. Perkins;Hongbin Gu;Kalina Boteva;Jeffrey A. Lieberman

  • How mental health care should change as a consequence of the COVID-19 pandemic.

    Carmen Moreno;Til Wykes;Til Wykes;Silvana Galderisi;Merete Nordentoft

  • Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III.

    Joseph Patrick McEvoy;Jonathan M. Meyer;Donald C. Goff;Henry A. Nasrallah

  • Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores

    Bjarni J. Vilhjálmsson;Jian Yang;Hilary K. Finucane;Alexander Gusev

  • Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

    Lon S. Schneider;Pierre N. Tariot;Karen S. Dagerman;Sonia M. Davis

  • Neurocognitive Effects of Antipsychotic Medications in Patients With Chronic Schizophrenia in the CATIE Trial

    Richard S.E. Keefe;Robert M. Bilder;Sonia M. Davis;Philip D. Harvey

  • Clozapine-induced agranulocytosis. Incidence and risk factors in the United States

    Jose Ma. J. Alvir;Jeffrey A. Lieberman;Allan Z. Safferman;Jeffrey L. Schwimmer

  • Duration of psychosis and outcome in first-episode schizophrenia.

    Antony D. Loebel;Jeffrey A. Lieberman;Jose M. Alvir;David I. Mayerhoff

  • Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs

    Seiya Miyamoto;Gary E Duncan;Christine E Marx;Jeffrey A Lieberman

  • Practice guideline for the treatment of patients with schizophrenia

    M. I. Herz;R. P. Liberman;T. H. McGlashan;J. A. Lieberman

  • Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.

    Robert M. Bilder;Robert S. Goldman;Delbert Robinson;Gail Reiter

  • Effectiveness of Clozapine Versus Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia Who Did Not Respond to Prior Atypical Antipsychotic Treatment

    Joseph Patrick McEvoy;Jeffrey A. Lieberman;T. Scott Stroup;Sonia M. Davis

  • Physical Health Monitoring of Patients With Schizophrenia

    Stephen R. Marder;Susan M. Essock;Alexander L. Miller;Robert W. Buchanan

  • Catching up on schizophrenia: natural history and neurobiology

    David A Lewis;Jeffrey A Lieberman

  • Brain volume in first-episode schizophrenia: systematic review and meta-analysis of magnetic resonance imaging studies.

    R Grant Steen;Courtney Mull;Robert McClure;Robert M Hamer

Frequent Co-Authors

James L. Kennedy
James L. Kennedy Centre for Addiction and Mental Health
Joseph P. McEvoy
Joseph P. McEvoy Augusta University
Herbert Y. Meltzer
Herbert Y. Meltzer Northwestern University
Diana O. Perkins
Diana O. Perkins University of North Carolina at Chapel Hill
John M. Kane
John M. Kane Zucker Hillside Hospital
Robert M. Bilder
Robert M. Bilder University of California, Los Angeles
Richard S.E. Keefe
Richard S.E. Keefe Duke University
Patrick F. Sullivan
Patrick F. Sullivan University of North Carolina at Chapel Hill
T. Scott Stroup
T. Scott Stroup Columbia University
Marvin S. Swartz
Marvin S. Swartz Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond studying Medicine in the USA, many students and professionals are exploring alternative healthcare career pathways. Online programs now make it easier and more affordable to enter fast-growing fields within healthcare.

For those interested in health data management, rhia certification programs online offer flexible study options and can lead to in-demand roles organizing and securing medical records. Another high-demand area is medical billing and coding. If you are wondering how much does it cost to become a medical coder, many online courses are budget-friendly and can prepare you for certification quickly.

Nursing also remains a popular career pathway. Prospective advanced practice nurses can search for the cheapest nurse practitioner programs that suit their educational goals. Registered nurses can alternatively pursue affordable nursing programs online to complete their education or specialize further without leaving their jobs.

These pathways offer flexibility and a strong career outlook for those seeking opportunities in healthcare beyond traditional medical school.

Best Scientists Citing Jeffrey A. Lieberman

Trending Scientists

Recently Published Articles